EFFICIENT AND SELECTIVE ANTITUMOR AGENTS BASED ON CATIONIC CALIXARENES: SYNTHESIS, CHARACTERIZATION, AND ANTIPROLIFERATIVE PROPERTIES

Year 2022, , 189 - 199, 01.03.2022

Mehmet Oğuz

https://doi.org/10.36306/konjes.1039091

Cited By: 1

Abstract

Research work on the preparation of anti-tumor agents with active properties is still a major field for the pharmaceutical industry to promote more potent anticancer drugs to the market. However, one of the main disadvantages of current and future anticancer drugs is selectivity. Therefore, in recent decades, a new perspective has to be developed for chemotherapy, such as "targeted" drugs and minimal side effects. Calixarenes, composed of phenolic units linked by methylene bridges are versatile kinds of macrocyclic compounds in supramolecular chemistry that can be modified to hydrophilic and hydrophobic cavities. The biocompatibility of calixarene derivatives allows them to be used in the development of in vivo and in vitro applications. For this reason, the calixarenes with different active groups, have been synthesized by many researchers as a target structure, and their biological activities and in particular their anti-cancer properties, have been studied. The purpose of the current study is to synthesize calix[4]arene derivatives bearing the cationic group at the lower rim and investigation their cytotoxic effect for several cancerous cells. Results demonstrated that calix[4]arene derivative having 5-bromopenty trimethylammonium bromide moieties (CN) and calix[4]arene derivative having 3-bromopropyl-triphenylphosphonium bromide moieties (CP) compounds selectively inhibits proliferation of A549 (13.42 µM) and HeLa (17.05 µM) and Hep-2 cells (>200 µM and 162.71 µM), respectively.

Keywords

Supramolecule, Calixarene, Cytotoxicity, Cationic, Anticancer Agent

Supporting Institution

Selçuk Üniversitesi BAP

Project Number

21401034

Thanks

We thank the Selcuk University, Konya (SUBAP-Grant Number: 21401034) for the financial support of this work.

Katyonik Kaliksarenlere Dayalı Etkili ve Seçici Antitümör Ajanlar: Sentez, Karakterizasyon ve Antiproliferatif Özellikler

Abstract

Aktif özelliklere sahip anti-tümör ajanların hazırlanmasına yönelik araştırma çalışmaları, farmasötik endüstrisinin piyasaya daha güçlü antikanser ilaçları tanıtması için hala önemli bir alandır. Bununla birlikte, mevcut ve gelecekteki antikanser ilaçlarının ana dezavantajlarından biri seçiciliktir. Bu nedenle, son yıllarda kemoterapi için "hedeflenen" ilaçlar ve minimal yan etkiler gibi yeni bir bakış açısı geliştirilmelidir. Metilen köprüleriyle bağlı fenolik birimlerden oluşan kaliksarenler, supramoleküler kimyada hidrofilik ve hidrofobik boşluklara dönüştürülebilen çok yönlü makrosiklik bileşiklerdir. Kaliksaren türevlerinin biyouyumluluğu, in vivo ve in vitro uygulamaların geliştirilmesinde kullanılmalarına izin verir. Bu nedenle farklı aktif gruplara sahip kaliksarenler birçok araştırmacı tarafından hedef yapı olarak sentezlenmiş ve biyolojik aktiviteleri ve özellikle kanser önleyici özellikleri incelenmiştir. Bu çalışmanın amacı, alt kenarda katyonik grubu taşıyan kaliks[4]aren türevlerini sentezlemek ve çeşitli kanserli hücreler için sitotoksik etkilerini araştırmaktır. Sonuçlar, CN ve CP bileşiklerinin sırasıyla A549 (13.42 uM) ve HeLa (17.05 uM) ve Hep-2 hücrelerinin (>200 uM ve 162.71 uM) proliferasyonunu seçici olarak engellediğini gösterdi.

Keywords

Supramolekül, Kaliksaren, Sitotoksisite, Katyonik, Antikanser Ajan

Project Number

21401034

References

• Akceylan, E., Erdermir, S., Ozcelik, E., Tabakci, B., 2021, “Removal of some phenolic pollutions from aqueous solutions by magnetic nanoparticles containing ımidazole-derivatized calix[4]arene”, Konya Journal of Engineering Sciences, 9 (2), 442-454.
• An, L., Han, L.-L., Zheng, Y.-G., Peng, X.-N., Xue, Y.-S., Gu, X.-K., Sun, J. and Yan, C.-G., 2016, "Synthesis, X-ray crystal structure and anti-tumor activity of calix[n]arene polyhydroxyamine derivatives", European Journal of Medicinal Chemistry, 123, 21-30.
• An, L., Wang, C., Han, L., Liu, J., Huang, T., Zheng, Y., Yan, C. and Sun, J., 2019, "Structural Design, Synthesis, and Preliminary Biological Evaluation of Novel Dihomooxacalix[4]arene-Based Anti-tumor Agents", Frontiers in chemistry, 7, 856.
• An, L., Wang, C., Zheng, Y.-G., Liu, J.-D. and Huang, T.-H., 2021, "Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities", European Journal of Medicinal Chemistry, 210, 112984.
• Cengel, F. and Farabi, T., 2021, "Removal of p-nitrophenol from aqueous solutions by calixarene based graphene oxide", Konya Journal of Engineering Sciences, 9, 79-90.
• Consoli, G. M. L., Granata, G., Fragassi, G., Grossi, M., Sallese, M. and Geraci, C., 2015, "Design and synthesis of a multivalent fluorescent folate–calix[4]arene conjugate: cancer cell penetration and intracellular localization", Organic & biomolecular chemistry, 13 (11), 3298-3307.
• de Fátima, Â., Fernandes, S. A. and Sabino, A. A., 2009, "Calixarenes as new platforms for drug design", Current Drug Discovery Technologies, 6 (2), 151-170.
• Dings, R. P., Levine, J. I., Brown, S. G., Astorgues-Xerri, L., MacDonald, J. R., Hoye, T. R., Raymond, E. and Mayo, K. H., 2013, "Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer", Investigational new drugs, 31 (5), 1142-1150.
• Erdemir, S., Oguz, M. and Malkondu, S., 2021, "A NIR fluorescent sensor based on thiazoline-isophorone with low cytotoxicity in living cells for Hg2+ detection through ICT associated hydrogen bonding effect", Analytica Chimica Acta, 339353.
• Geraci, C., Consoli, G. M., Galante, E., Bousquet, E., Pappalardo, M. and Spadaro, A., 2008, "Calix [4] arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation", Bioconjugate chemistry, 19 (3), 751-758.
• Läppchen, T., Dings, R. P., Rossin, R., Simon, J. F., Visser, T. J., Bakker, M., Walhe, P., Van Mourik, T., Donato, K. and Van Beijnum, J. R., 2015, "Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F] fluoroethylazide, and in vivo evaluation", European Journal of Medicinal Chemistry, 89, 279-295.
• Naseer, M. M., Ahmed, M. and Hameed, S., 2017, "Functionalized calix[4]arenes as potential therapeutic agents," Chemical biology & drug design, 89 (2), 243-256.
• Nimse, S. B. and Kim, T., 2013, "Biological applications of functionalized calixarenes," Chemical Society Reviews, 42 (1), 366-386.
• Oguz, M., Gul, A., Karakurt, S. and Yilmaz, M., 2020, "Synthesis and evaluation of the antitumor activity of Calix[4]arene L-proline derivatives", Bioorganic chemistry, 94, 103207.
• Oguz, M., Gul, A., Karakurt, S. and Yilmaz, M., 2020, "Synthesis of New Picolylamine Bearing Calix[8]arene Derivatives as Antiproliferative Agents for Colorectal Carcinoma", ChemistrySelect, 5 (39), 12250-12254.
• Oguz, M., Kalay, E., Akocak, S., Nocentini, A., Lolak, N., Boga, M., Yilmaz, M. and Supuran, C. T., 2020, "Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action", Journal of enzyme inhibition and medicinal chemistry, 35 (1), 1215-1223.
• Oguz, M., Alizada, M., Gul, A., Kursunlu, A. N. and Yilmaz, M., 2021, "A basket-type fluorescent sensor based calix[4]azacrown ether for multi-analytes: Practicability in living cells and real sample", Microchemical Journal, 167, 106279.
• Ozcelik, E., Farabi, T. and Tabakci, M., 2019, "Sensing of p-nitrophenol in aqueous media on qcm sensor coated with calixarene derivative ımmobilized merrifield resin", Konya Journal of Engineering Sciences, 7 (3), 595-603.
• Pur, F. N., 2016, "Calixdrugs: calixarene-based clusters of established therapeutic drug agents", Molecular diversity, 20 (3), 781-787.
• Rego, Y. F., da Silva, C. M., da Silva, D. L., da Silva, J. G., Ruiz, A. L. T., de Carvalho, J. E., Fernandes, S. A. and de Fatima, A., 2019, "Phthalazine-triones: Calix[4]arene-assisted synthesis using green solvents and their anticancer activities against human cancer cells", Arabian journal of chemistry, 12 (8), 4065-4073.
• Rodik, R. V., Boyko, V. I. and Kalchenko, V. I., 2009, "Calixarenes in bio-medical researches", Current Medicinal Chemistry, 16 (13), 1630-1655.
• Rouge, P., Pires, V. S., Gaboriau, F., Dassonville-Klimpt, A., Guillon, J., Nascimento, S. D., Leger, J.-M., Lescoat, G. and Sonnet, P., 2010, "Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes", Journal of enzyme inhibition and medicinal chemistry, 25 (2), 216-227.
• Saluja, V. and Sekhon, B. S., 2013, "Calixarenes and cucurbiturils: pharmaceutial and biomedical applications", Journal of Pharmaceutical Education and Research, 4 (1), 16.
• Santos, D., Medeiros-Silva, J., Cegonho, S., Alves, E., Ramilo-Gomes, F., Santos, A. O., Silvestre, S. and Cruz, C., 2015, "Cell proliferation effects of calix[4]arene derivatives", Tetrahedron, 71 (40), 7593-7599.
• Sayin, S. and Yilmaz, M., 2017, "Synthesis of environmentally friendly, efficient and highly recyclable Lewis acid-type calix[4]arene catalysts containing flexible or bulky groups for the Mannich reaction", RSC advances, 7 (18), 10748-10756.
• Siegel, R. L., Miller, K. D. and Jemal, A., 2019, "Cancer statistics, 2019", CA: A Cancer Journal for Clinicians, 69 (1), 7-34.
• Yilmaz, B., Bayrac, A. T. and Bayrakci, M., 2020, "Evaluation of anticancer activities of novel facile synthesized calix[n]arene sulfonamide analogs", Applied biochemistry and biotechnology, 190 (4), 1484-1497.
• Yousaf, A., Abd Hamid, S., Bunnori, N. M. and Ishola, A., 2015, "Applications of calixarenes in cancer chemotherapy: facts and perspectives", Drug design, development and therapy, 9, 2831.
• Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X. and Huang, F., 2021, "Supramolecular cancer nanotheranostics", Chemical Society Reviews, 50 (4), 2839-2891.